BR0113579A - Proteìnas sintéticas modificadas por polìmero - Google Patents

Proteìnas sintéticas modificadas por polìmero

Info

Publication number
BR0113579A
BR0113579A BR0113579-1A BR0113579A BR0113579A BR 0113579 A BR0113579 A BR 0113579A BR 0113579 A BR0113579 A BR 0113579A BR 0113579 A BR0113579 A BR 0113579A
Authority
BR
Brazil
Prior art keywords
proteins
polymer modified
modified synthetic
synthetic proteins
polypeptides
Prior art date
Application number
BR0113579-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Gerd Kochendoerfer
Paolo Botti
James A Bradburne
Shiah-Yun Chen
Sonya Cresman
Christie L Hunter
Stephen B H Kent
Donald W Low
Jil G Wilken
Kochendoerfer Gerd
Original Assignee
Gryphon Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gryphon Therapeutics Inc filed Critical Gryphon Therapeutics Inc
Priority claimed from PCT/US2001/021930 external-priority patent/WO2002020033A1/fr
Publication of BR0113579A publication Critical patent/BR0113579A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/80—Cytochromes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
BR0113579-1A 2000-09-08 2001-07-12 Proteìnas sintéticas modificadas por polìmero BR0113579A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23133900P 2000-09-08 2000-09-08
PCT/US2001/021930 WO2002020033A1 (fr) 2000-09-08 2001-07-12 Proteines de synthese modifiees par des polymeres

Publications (1)

Publication Number Publication Date
BR0113579A true BR0113579A (pt) 2003-06-17

Family

ID=22868813

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0113623-2A BR0113623A (pt) 2000-09-08 2001-07-12 Proteìnas sintéticas de estìmulo da eritropoiese
BR0113579-1A BR0113579A (pt) 2000-09-08 2001-07-12 Proteìnas sintéticas modificadas por polìmero

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR0113623-2A BR0113623A (pt) 2000-09-08 2001-07-12 Proteìnas sintéticas de estìmulo da eritropoiese

Country Status (12)

Country Link
EP (1) EP1315738A4 (fr)
JP (2) JP2004508383A (fr)
KR (1) KR20030061785A (fr)
CN (1) CN1452632A (fr)
AU (2) AU2001288937B2 (fr)
BR (2) BR0113623A (fr)
CA (1) CA2412298A1 (fr)
ES (1) ES2360203T3 (fr)
IL (1) IL154015A0 (fr)
MX (1) MXPA03001450A (fr)
WO (1) WO2002020557A1 (fr)
ZA (3) ZA200300315B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4559219B2 (ja) * 2002-06-10 2010-10-06 エミリン ファーマシューティカルズ インコーポレイテッド 化学連結による収束性タンパク質合成のための開裂後硫黄脱保護
WO2004061094A1 (fr) 2002-12-30 2004-07-22 Gryphon Therapeutics, Inc. Composes thioesters et selenoesters hydrosolubles et leurs procedes de production et d'utilisation
JP5014148B2 (ja) * 2005-10-25 2012-08-29 独立行政法人理化学研究所 ペプチドチオエステルの製造方法
WO2011017837A1 (fr) * 2009-08-12 2011-02-17 Xuechen Li Ligature chimique native sur les sites de la sérine et de la thréonine
FR2952058B1 (fr) * 2009-10-29 2013-10-04 Centre Nat Rech Scient Procede de ligation native de polypeptides
CN115058426B (zh) * 2022-05-16 2024-07-16 上海志药科技有限公司 一种特异性识别SARS-CoV-19的核酸分子探针及其筛选方法、检测产品和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184344B1 (en) * 1995-05-04 2001-02-06 The Scripps Research Institute Synthesis of proteins by native chemical ligation
US6307018B1 (en) * 1996-12-24 2001-10-23 The Scripps Research Institute General chemical ligation
WO1998028434A1 (fr) * 1996-12-24 1998-07-02 The Scripps Research Institute Ligature chimique generale

Also Published As

Publication number Publication date
BR0113623A (pt) 2004-06-22
WO2002020557A1 (fr) 2002-03-14
ZA200300659B (en) 2004-03-05
EP1315738A4 (fr) 2006-06-07
AU2001288937B2 (en) 2005-04-28
CA2412298A1 (fr) 2002-03-14
AU8893701A (en) 2002-03-22
MXPA03001450A (es) 2004-12-13
IL154015A0 (en) 2003-07-31
ES2360203T3 (es) 2011-06-01
ZA200300314B (en) 2004-02-04
ZA200300315B (en) 2004-02-04
KR20030061785A (ko) 2003-07-22
CN1452632A (zh) 2003-10-29
JP2008150393A (ja) 2008-07-03
EP1315738A1 (fr) 2003-06-04
JP2004508383A (ja) 2004-03-18

Similar Documents

Publication Publication Date Title
NO20031047D0 (no) Polymermodifiserte syntetiske proteiner
HRP20020880B1 (en) New pharmaceutical composition
DE59010941D1 (de) TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
ES2109945T3 (es) Composiciones y procedimientos para identificar moleculas biologicamente activas.
BR0113822A (pt) Vacina
BR0107036A (pt) Grânulos à base de amido e de lactose
BR0107888A (pt) Pirrolidinas 1,3-dissubstituidas como antagonistas de alfa-2adrenorreceptor
BRPI0413495A (pt) reagentes de peptìdeos especìficos para prìons e seus usos
BR9911682A (pt) Metano sulfonato de paroxetina
BR0016032A (pt) Colágeno
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
DE3672950D1 (de) Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung.
ES2108258T3 (es) Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.
BR0013638A (pt) Novas moléculas semelhantes a interferon beta
BR0113579A (pt) Proteìnas sintéticas modificadas por polìmero
FR2768341B1 (fr) Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides
FR2708198B1 (fr) Composition cosmétique ou pharmaceutique, notamment dermatologique contenant un extrait de Tephrosia, en particulier Tephrosia purpurea.
ES2176459T3 (es) Patrones y soluciones de contraste estabilizados.
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ATE164311T1 (de) Orale, pharmazeutische zusammensetzungen das ein protein oder peptide, eine antikoerper und polymerkugeln enthalten
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
BR9809457A (pt) Sais de peptìdeo de bpc com atividade organo-protetora, o processo para sua preparação e seu uso em terapia.
ATE311456T1 (de) Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln
FI971872A (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: GRYPHON THERAPEUTICS, INC. (US)

Free format text: A FIM DE ATENDER O SOLICITADO NA PETICAO DE TRANSFERENCIA NO 020070035353/RJ DE 22/03/2007, QUEIRAREAPRESENTAR O DOCUMENTO DE CESSAO ASSINADO PELA CEDENTE, CESSIONARIA E DUAS TESTEMUNHAS E COM A DEVIDA NOTARIZACAO E LEGALIZACAO CONSULAR.

B25C Requirement related to requested transfer of rights

Owner name: GRYPHON THERAPEUTICS, INC. (US)

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 020080024974/RJ DE 20/02/2008, QUEIRA APRESENTAR A LEGALIZACAO CONSULAR.

B25A Requested transfer of rights approved

Owner name: AMYLIN PHARMACEUTICALS, INC. (US)

Free format text: TRANSFERIDO DE: GRYPHON THERAPEUTICS, INC.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ,9A,10A,11A E 12A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2206 DE 16/04/2013.